ArticleBiomacromolecules2021

Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.

Yaping Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.